Sunshine Biopharma, Inc. entered into an engagement agreement with Aegis Capital Corp. on March 6, 2026. The agreement is filed as Exhibit 99.1 with the 8-K filing dated March 9, 2026.
Key takeaways
Entered engagement agreement with Aegis Capital Corp. on 2026-03-06